CoChat

A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer's disease

Open access
Ma, Suk Ling, Tang, Nelson Leung Sang, Tam, Cindy Woon Chi, Lui, Victor Wing Cheong, Lam, Linda Chiu Wa, Chiu, Helen Fung Kum, Driver, Jane Ann, Pastorino, Lucia, Lu, Kun Ping · 2012 · Neurobiology of Aging
Cited by 74

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Alzheimer’s disease (AD), the most common form of dementia, is characterized by the presence of neurofibrillary tangles composed of tau and senile plaques of amyloid-beta peptides (Aβ) derived from amyloid precursor protein (APP). Pin1 is a unique prolyl isomerase that has been shown to protect against age-dependent neurodegeneration by acting on phosphorylated tau and APP to suppress tangle formation and amyloidogenic APP processing. Here we report a functional polymorphism, rs2287839, in the Pin1 promoter that is significantly associated with a 3-year delay in the average age-at-onset (AAO) of late-onset AD in a Chinese population. More significantly, the Pin1 polymorphism rs2287839 is located within the consensus binding motif for the brain-selective transcription factor, AP4 (CAGCTG) and almost completely abolishes the ability of AP4 to bind and suppress the Pin1 promoter, as shown by chromatin immunoprecipitation, electrophoretic mobility shift assay and promoter luciferase assay. Moreover, overexpression or knockdown of AP4 resulted in an 80% reduction or two-fold increase in endogenous Pin1 levels, respectively. Thus, AP4 is a novel transcriptional repressor of Pin1 expression and the Pin1 promoter SNP identified in this study that prevents such suppression is associated with delayed onset of AD. These results indicate that regulation of Pin1 by AP4 plays a critical role in determining AAO of AD and might be a novel therapeutic target to delay the onset of AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2010.05.018

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 52

  1. Bettens, 2010, Current status on Alzheimer disease molecular genetics: from past, to present, to future, Hum. Mol. Genet, 19, R4, 10.1093/hmg/ddq142 · DOI · Paper page
  2. Brookmeyer, 1998, Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset, Am. J. Public Health, 88, 1337, 10.2105/AJPH.88.9.1337 · DOI · Paper page
  3. Brouwers, 2008, Molecular genetics of Alzheimer's disease: an update, Ann. Med, 40, 562, 10.1080/07853890802186905 · DOI · Paper page
  4. Butler, 2009, Meta-analysis of linkage studies for Alzheimer's disease − a web resource, Neurobiol. Aging, 30, 1037, 10.1016/j.neurobiolaging.2009.03.013 · DOI
  5. Butterfield, 2006, Pin1 in Alzheimer's disease, J. Neurochem, 98, 1697, 10.1111/j.1471-4159.2006.03995.x · DOI · Paper page
  6. Cathcart, 2005, Cystatin C as a risk factor for Alzheimer disease, Neurology, 64, 755, 10.1212/01.WNL.0000151980.42337.44 · DOI · Paper page
  7. Chiu, 1994, Reliability and validity of the Cantonese version of the Mini-Mental State Examination − A preliminary study, J. Hong Kong Collège Psychiatr, 4, 25
  8. Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261, 921, 10.1126/science.8346443 · DOI · Paper page
  9. Cui, 1998, Exon-I is involved in positive as well as negative regulation of human angiotensinogen gene expression, Gene, 224, 97, 10.1016/S0378-1119(98)00512-5 · DOI
  10. Dickson, 2008, A genomic scan for age at onset of Alzheimer's disease in 437 families from the NIMH Genetic Initiative, Am. J. Med. Genet. B Neuropsychiatr. Genet, 147B, 784, 10.1002/ajmg.b.30689 · DOI
  11. Guerreiro, 2010, Genetic variability in CLU and its association with Alzheimer's disease, PLoS One, 5, e9510, 10.1371/journal.pone.0009510 · DOI · Paper page
  12. Han, 2010, The functional promoter polymorphism (−842G > C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and younger, Breast Cancer Res. Treat, 122, 243, 10.1007/s10549-009-0682-9 · DOI
  13. Heinemeyer, 1998, Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL, Nucleic Acids Res, 26, 362, 10.1093/nar/26.1.362 · DOI · Paper page
  14. Holmans, 2005, Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease, Am. J. Med. Genet. B Neuropsychiatr. Genet, 135B, 24, 10.1002/ajmg.b.30114 · DOI · Paper page
  15. Hu, 1990, Transcription factor AP-four contains multiple dimerization domains that regulate dimer specificity, Genes Dev, 4, 1741, 10.1101/gad.4.10.1741 · DOI · Paper page
  16. Imai, 2006, Transcriptional repression of human immunodeficiency virus type 1 by AP-4, J. Biol. Chem, 281, 12495, 10.1074/jbc.M511773200 · DOI
  17. Jowett, 2004, Genetic variation in BEACON influences quantitative variation in metabolic syndrome-related phenotypes, Diabetes, 53, 2467, 10.2337/diabetes.53.9.2467 · DOI
  18. Jung, 2008, AP4 encodes a c-MYC-inducible repressor of p21, Proc. Natl. Acad. Sci. U. S. A., 105, 15046, 10.1073/pnas.0801773105 · DOI · Paper page
  19. Kamboh, 2006, Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures, Mol. Psychiatry, 11, 273, 10.1038/sj.mp.4001775 · DOI
  20. Kim, 2006, A repressor complex, AP4 transcription factor and geminin, negatively regulates expression of target genes in nonneuronal cells, Proc. Natl. Acad. Sci. U. S. A, 103, 13074, 10.1073/pnas.0601915103 · DOI
  21. Kohnken, 2000, Detection of tau phosphorylated at threonine two hundred and thirty-one in cerebrospinal fluid of Alzheimer's disease patients, Neurosci. Lett, 287, 187, 10.1016/S0304-3940(00)01178-2 · DOI · Paper page
  22. Lambert, 2006, Association study of the PIN1 gene with Alzheimer's disease, Neurosci. Lett, 402, 259, 10.1016/j.neulet.2006.04.010 · DOI
  23. Lambert, 2009, Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease, Nat. Genet, 41, 1094, 10.1038/ng.439 · DOI · Paper page
  24. Lee, 2009, Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance, Nat. Cell Biol, 11, 97, 10.1038/ncb1818 · DOI
  25. Li, 2003, Glutathione S-transferase omega-one modifies age-at-onset of Alzheimer disease and Parkinson disease, Hum. Mol. Genet, 12, 3259, 10.1093/hmg/ddg357 · DOI · Paper page
  26. Lim, 2008, Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy, J. Clin. Invest, 118, 1877
  27. Lim, 2005, Pinning down phosphorylated tau and tauopathies, Biochim. Biophys. Acta, 1739, 311, 10.1016/j.bbadis.2004.10.003 · DOI
  28. Liou, 2003, Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration, Nature, 424, 556, 10.1038/nature01832 · DOI · Paper page
  29. Lu, 2009, A novel functional variant (−842G > C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity, Carcinogenesis, 30, 1717, 10.1093/carcin/bgp171 · DOI
  30. Lu, 2004, Pinning down cell signaling, cancer and Alzheimer's disease, Trends Biochem. Sci, 29, 200, 10.1016/j.tibs.2004.02.002 · DOI · Paper page
  31. Lu, 2007, Prolyl cis-trans isomerization as a molecular timer, Nat. Chem. Biol, 3, 619, 10.1038/nchembio.2007.35 · DOI · Paper page
  32. Lu, 1996, A human peptidyl-prolyl isomerase essential for regulation of mitosis, Nature, 380, 544, 10.1038/380544a0 · DOI · Paper page
  33. Lu, 2007, The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease, Nat. Rev. Mol. Cell Biol, 8, 904, 10.1038/nrm2261 · DOI · Paper page
  34. Ma, 2005, The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease, Neurobiol. Aging, 26, 1005, 10.1016/j.neurobiolaging.2004.08.010 · DOI
  35. Ma, 2009, Polymorphisms of the estrogen receptor alpha (ESR1) gene and the risk of Alzheimer's disease in a southern Chinese community, Int. Psychogeriatr, 21, 977, 10.1017/S1041610209990068 · DOI
  36. Ma, 2008, Association of prostaglandin-endoperoxide synthase2 (PTGS2) in polymorphisms and Alzheimer's disease in Chinese, Neurobiol. Aging, 29, 856, 10.1016/j.neurobiolaging.2006.12.011 · DOI
  37. Maudsley, 2006, Protein twists and turns in Alzheimer disease, Nat. Med, 12, 392, 10.1038/nm0406-392 · DOI
  38. Mermod, 1988, Enhancer binding factors AP-four and AP-1 act in concert to activate SV40 late transcription in vitro, Nature, 332, 557, 10.1038/332557a0 · DOI · Paper page
  39. Nowotny, 2007, Association studies between common variants in prolyl isomerase Pin1 and the risk for late-onset Alzheimer's disease, Neurosci. Lett, 419, 15, 10.1016/j.neulet.2007.03.071 · DOI
  40. Ranganathan, 1997, Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent, Cell, 89, 875, 10.1016/S0092-8674(00)80273-1 · DOI · Paper page
  41. Ryo, 2002, PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells, Mol. Cell. Biol, 22, 5281, 10.1128/MCB.22.15.5281-5295.2002 · DOI · Paper page
  42. Sciacca, 2003, Interleukin-1B polymorphism is associated with age at onset of Alzheimer's disease, Neurobiol. Aging, 24, 927, 10.1016/S0197-4580(03)00011-3 · DOI
  43. Segat, 2007, PIN1 promoter polymorphisms are associated with Alzheimer's disease, Neurobiol. Aging, 28, 69, 10.1016/j.neurobiolaging.2005.11.009 · DOI
  44. Sultana, 2006, Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis, Neurobiol. Aging, 27, 918, 10.1016/j.neurobiolaging.2005.05.005 · DOI · Paper page
  45. Tang, 2006, Evaluation of an algorithm of tagging SNPs selection by linkage disequilibrium, Clin. Biochem, 39, 240, 10.1016/j.clinbiochem.2005.11.014 · DOI
  46. Waring, 2008, Genome-wide association studies in Alzheimer disease, Arch. Neurol, 65, 329, 10.1001/archneur.65.3.329 · DOI · Paper page
  47. Wijsman, 2004, Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p132, Am. J. Hum. Genet, 75, 398, 10.1086/423393 · DOI · Paper page
  48. Wulf, 2005, Phosphorylation-specific prolyl isomerization: is there an underlying theme?, Nat. Cell Biol, 7, 435, 10.1038/ncb0505-435 · DOI · Paper page
  49. Yaffe, 1997, Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism, Science, 278, 1957, 10.1126/science.278.5345.1957 · DOI · Paper page
  50. Yap, 2003, Adaptor protein complex 4 (AP-4) is expressed in the central nervous system neurons and interacts with glutamate receptor delta2, Mol. Cell. Neurosci, 24, 283, 10.1016/S1044-7431(03)00164-7 · DOI
  51. Zhou, 2000, Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins, Mol. Cell, 6, 873, 10.1016/S1097-2765(05)00083-3 · doi:10.1016/s1097-2765(05)00083-3 · Paper page
  52. Zhou, 1999, Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism, Cell. Mol. Life Sci, 56, 788, 10.1007/s000180050026 · DOI

Cited by

See all 74

Metadata

Authors
Ma, S. L., Tang, N. L. S., Tam, C. W. C., Lui, V. W. C., Lam, L. C. W., Chiu, H. F. K., Driver, J. A., Pastorino, L., & Lu, K. P.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2012-04
Volume
33
Issue
4
Pages
804-813
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2073109388
Cited by
74
References
11
FWCI
2.85
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
NIH (R01AG017870, R01GM058556)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2010.05.018
The paper
Ma, S. L., Tang, N. L. S., Tam, C. W. C., Lui, V. W. C., Lam, L. C. W., Chiu, H. F. K., Driver, J. A., Pastorino, L., & Lu, K. P. (2012). A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer's disease. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2010.05.018

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.